Show simple item record

dc.creatorJin,Ying
dc.creatorZhao,Chunzhe
dc.creatorChen,Lihui
dc.creatorLiu,Xiangyu
dc.creatorPan,Shuxiao
dc.creatorJu,Dongsheng
dc.creatorMa,Jing
dc.creatorLi,Jinying
dc.creatorWei,Bo
dc.date2016-01-01
dc.date.accessioned2019-05-02T21:22:32Z
dc.date.available2019-05-02T21:22:32Z
dc.identifierhttps://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0716-97602016000100003
dc.identifier.urihttp://revistaschilenas.uchile.cl/handle/2250/82608
dc.descriptionBACKGROUND: The aim of this study was to explore epilepsy-related mechanism so as to figure out the possible targets for epilepsy treatment. METHODS: The gene expression profile dataset GES32534 was downloaded from Gene Expression Omnibus database. We identified the differentially expressed genes (DEGs) by Affy package. Then the DEGs were used to perform gene ontology (GO) and pathway enrichment analyses. Furthermore, a protein-protein interaction (PPI) network was constructed with the DEGs followed by co-expression modules construction and analysis. RESULTS: Total 420 DEGs were screened out, including 214 up-regulated and 206 down-regulated genes. Functional enrichment analysis revealed that down-regulated genes were mainly involved in the process of immunity regulation and biological repairing process while up-regulated genes were closely related to transporter activity. PPI network analysis showed the top ten genes with high degrees were all down-regulated, among which FN1 had the highest degree. The up-regulated and down-regulated DEGs in the PPI network generated two obvious sub-co-expression modules, respectively. In up-co-expression module, SCN3B (sodium channel, voltage gated, type III beta subunit) was enriched in GO:0006814 ~ sodium ion transport. In down-co-expression module, C1QB (complement C1s), CIS (complement component 1, S subcomponent) and CFI (complement factor I) were enriched in GO:0006955 ~ immune response. CONCLUSION: The immune response and complement system play a major role in the pathogenesis of epilepsy. Additionally, C1QB, C1S, CFI, SCN3B and FN1 may be potential therapeutic targets for epilepsy.
dc.formattext/html
dc.languageen
dc.publisherSociedad de Biología de Chile
dc.relation10.1186/s40659-015-0060-5
dc.rightsinfo:eu-repo/semantics/openAccess
dc.sourceBiological Research v.49 2016
dc.subjectEpilepsy
dc.subjectDifferentially expressed genes
dc.subjectFunctional annotation
dc.subjectProtein-protein interaction network
dc.subjectCo-expression module
dc.titleIdentification of novel gene and pathway targets for human epilepsy treatment


This item appears in the following Collection(s)

Show simple item record